Processa Pharmaceuticals Q3'26 Earnings Preview: EPS Estimate at (1.00) USD
Processa Pharmaceuticals is scheduled to report Q3'26 results on October 29. EPS is anticipated at (1.00) USD; the report time is not specified.
PCSA (Processa Pharmaceuticals, Inc.) is set to announce its Q3'26 results on October 29, time not specified. The earnings are expected to be disclosed at 8:00 AM ET (12:00 PM UTC).For Q3'26, EPS (earnings per share) is anticipated at (1.00) USD. Learn more details at PCSA Financials page.Revenue…